Date:30-Apr-2024  Time: 6:42 AM
 
 
        
Indo US Bio-Tech Ltd
Quarters:       (Rs. In Crores)
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
Type3Qtr2Qtr1Qtr4Qtr
Net Sales22.1115.8119.1418.11
Other Income0.080.000.030.02
Total Income22.1915.8219.1718.13
Total Expenditure 17.8713.2216.1515.45
Operating Profit4.322.603.022.68
Interest0.370.410.370.28
Gross Profit3.942.192.652.39
Depreciation0.190.210.200.26
Tax0.090.350.120.08
Deferred Tax-0.02-0.04-0.04-0.04
Reported Profit After Tax3.681.672.372.10
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com